Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.53 |
| ▸ | PPARA | Q07869 | 1/20 | 0.53 |
| ▸ | STING1 | Q86WV6 | 1/20 | 0.53 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.50 |
| ▸ | NOX4 | Q9NPH5 | 2/20 | 0.48 |
| ▸ | LCK | P06239 | 2/20 | 0.48 |
| ▸ | RGS12 | O14924 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | EGFR | P00533 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | CAMKK2 | Q96RR4 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | CNR1 | P21554 | 1/20 | 0.47 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.46 |
| ▸ | BCL2A1 | Q16548 | 1/20 | 0.46 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.46 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.46 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.46 |
| ▸ | TMPRSS4 | Q9NRS4 | 1/20 | 0.46 |
| ▸ | RORC | P51449 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4116154 | 0.99 | KDM4C (0.52) | KDM4CPPARASTING1FFAR1NOX4 | |
| Sulfuric Acid SCHEMBL1170031 | 0.95 | PPARA (0.49) | KDM4CPPARASTING1FFAR1NOX4 | |
| SCHEMBL609853 | 0.92 | KDM4C (0.51) | KDM4CPPARASTING1FFAR1NOX4 | |
| SCHEMBL608886 | 0.90 | KDM4C (0.50) | KDM4CPPARASTING1NOX4LCK | |
| SCHEMBL29390264 | 0.88 | KDM4C (0.69) | KDM4CPPARASTING1FFAR1NOX4 | |
| SCHEMBL607106 | 0.88 | KDM4C (0.69) | KDM4CPPARASTING1FFAR1NOX4 | |
| Potassium Ion SCHEMBL4116152 | 0.87 | RORC (0.47) | KDM4CPPARASTING1FFAR1CNR1 | |
| SCHEMBL608043 | 0.86 | CNR1 (0.52) | KDM4CPPARASTING1FFAR1NOX4 | |
| SCHEMBL29390970 | 0.86 | CNR1 (0.52) | KDM4CPPARASTING1FFAR1NOX4 | |
| SCHEMBL1169878 | 0.86 | EGFR (0.52) | FFAR1NOX4EGFRMAPTCNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 249 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4744114-A1 | POLYMER COMPOSITIONS, FILMS, AND BATTERIES, AND METHODS OF MANUFACTURE AND DECOMPOSITION | Piersica, Inc. (US) | 2026-05-20 | — | — | EP | claimed |
| EP-4721732-A1 | PHARMACEUTICAL COMPOSITION CONTAINING CRISDESALAZINE WITH IMPROVED STABILITY AND DISSOLUTION RATE | GNT Pharma Co., Ltd. (KR) | 2026-04-08 | — | — | EP | claimed |
| EP-4620045-A1 | POLYMER COMPOSITION AND METHODS FOR MAKING SAME | Piersica, Inc. (US) | 2025-09-24 | — | — | EP | claimed |
| EP-3902536-B1 | COMPOSITIONS COMPRISING 5-BENZYLAMINOSALICYLIC ACID COMPOUNDS FOR USE IN TREATING NEURODEGENERATIVE DISORDERS IN A COMPANION ANIMAL | GNT PHARMA CO LTD (KR) | 2025-09-03 | — | — | EP | claimed |
| US-20250257164-A1 | SOLID STATE BATTERIES | Piersica, Inc. (US) | 2025-08-14 | — | — | US | claimed |
| US-20250219045-A1 | POLYMER-BASED COMPONENTS FOR SOLID-STATE LITHIUM-ION BATTERIES AND METHODS OF MANUFACTURE | PIERSICA INC. | 2025-07-03 | — | — | US | claimed |
| US-12338307-B2 | Solid state batteries | Piersica, Inc. (US) | 2025-06-24 | — | — | US | claimed |
| US-20250177418-A1 | NEUROACTIVE STEROIDS FOR TREATMENT OF GASTROINTESTINAL DISEASES OR CONDITIONS | SAGE THERAPEUTICS, INC. | 2025-06-05 | — | — | US | claimed |
| US-20250170147-A1 | NEUROACTIVE STEROIDS FOR TREATMENT OF GASTROINTESTINAL DISEASES OR CONDITIONS | SAGE THERAPEUTICS, INC. | 2025-05-29 | — | — | US | claimed |
| US-20250170149-A1 | NEUROACTIVE STEROIDS FOR TREATMENT OF GASTROINTESTINAL DISEASES OR CONDITIONS | SAGE THERAPEUTICS, INC. | 2025-05-29 | — | — | US | claimed |
| US-20090240079-A1 | Pharmaceutical Composition for Treating or Preventing Degenerative and Inflammatory Diseases | NEUROTECH PHARMACEUTICALS CO., LTD. (KR) | 2009-09-24 | — | — | US | claimed |
| CN-101538218-A | Pharmaceutical composition for treating or preventing degenerative and inflammatory diseases | NEUROTECH CO LTD | 2009-09-23 | — | — | CN | claimed |
| US-20090149542-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING NEURONAL DEATH OR NEUROLOGICAL DYSFUNCTION | NEUROTECH PHARMACEUTICALS CO., LTD. (KR) | 2009-06-11 | — | — | US | claimed |
| WO-2009064084-A2 | MANUFACTURING METHOD OF 2-HYDROXY-5-PHENYLALKYLAMINOBENZOIC ACID DERIVATIVES AND THEIR SALTS | NEUROTECH CO., LTD. (KR) | 2009-05-22 | — | — | WO | claimed |
| CN-101426484-A | Pharmaceutical composition for treating or preventing degenerative and inflammatory diseases | NEUROTECH CO LTD (KR) | 2009-05-06 | — | — | CN | claimed |
| WO-2009045083-A2 | COMBINATION THERAPY FOR NEUROPROTECTION | S.H. PHARMA., LTD (KR) | 2009-04-09 | — | — | WO | claimed |
| EP-2004164-A1 | PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING DEGENERATIVE AND INFLAMMATORY DISEASES | Neurotech Co., Ltd. (KR) | 2008-12-24 | — | — | EP | claimed |
| US-20070298129-A1 | Compounds and compositions for treating neuronal death or neurological dysfunction | NEUROTECH PHARMACEUTICALS CO., LTD. (KR) | 2007-12-27 | — | — | US | claimed |
| WO-2007119973-A1 | PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING DEGENERATIVE AND INFLAMMATORY DISEASES | NEUROTECH CO., LTD. (KR) | 2007-10-25 | — | — | WO | claimed |
| US-20070049565-A1 | Combination of cell necrosis inhibitor and lithium for treating neuronal death or neurological dysfunction | NEUROTECH PHARMACEUTICALS CO., LTD. (KR) | 2007-03-01 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090149542-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING NEURONAL DEATH OR NEUROLOGICAL DYSFUNCTION | BCL2, BAX, SMN1; SMN2 | KDM4C 3544/4885PPARA 1265/4885STING1 3945/4885 |
| US-20250170147-A1 | NEUROACTIVE STEROIDS FOR TREATMENT OF GASTROINTESTINAL DISEASES OR CONDITIONS | MC2R, CRH, NTSR2 | KDM4C 4817/4885PPARA 845/4885STING1 3211/4885 |
| US-20250170149-A1 | NEUROACTIVE STEROIDS FOR TREATMENT OF GASTROINTESTINAL DISEASES OR CONDITIONS | MC2R, CRH, NTSR2 | KDM4C 4817/4885PPARA 845/4885STING1 3211/4885 |
| US-20090240079-A1 | Pharmaceutical Composition for Treating or Preventing Degenerative and Inflammatory Diseases | ALOX12, ALOX15, ALOX15B | KDM4C 4051/4885PPARA 223/4885STING1 3665/4885 |
| US-20250177418-A1 | NEUROACTIVE STEROIDS FOR TREATMENT OF GASTROINTESTINAL DISEASES OR CONDITIONS | MC2R, CRH, NTSR2 | KDM4C 4817/4885PPARA 845/4885STING1 3211/4885 |
| US-20070298129-A1 | Compounds and compositions for treating neuronal death or neurological dysfunction | BCL2, BAX, SMN1; SMN2 | KDM4C 3544/4885PPARA 1265/4885STING1 3945/4885 |
| US-20070049565-A1 | Combination of cell necrosis inhibitor and lithium for treating neuronal death or neurological dysfunction | BAD, MAP1LC3B, XIAP | KDM4C 4402/4885PPARA 4072/4885STING1 3607/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.